Lv4
570 积分 2023-11-15 加入
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
3天前
已完结
Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
18天前
已完结
Synthetic Approaches to the New Drugs Approved During 2022
18天前
已完结
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
18天前
已完结
Pan-RAF:MEK Molecular Glues Take Center Stage
26天前
已完结
Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO)
1个月前
已完结
Perfluoro-tert-butanol for selective on-resin detritylation: a mild alternative to traditionally used methods
1个月前
已完结
Remodeling cyclophilin A to target KRAS
1个月前
已完结
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
1个月前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
1个月前
已完结
皖公网安备34019202002308
